baber/WOPTO huggingface dataset:
Patent NZ-513471-A (NZ)
Title: Tool for treating fractured or diseased bone using expandable bodies deployed by catheter
Inventor: SCHOLTEN ARIE
IPC: A61B19/00
Filed: 1998-06-01
Abstract: A tool for treating bone comprising an outer catheter tube having a distal end region, an inner catheter tube extending within the outer catheter tube and having a distal end region that extends beyond the distal end region of the outer catheter tube, and an expandable structure having a proximal end secured to the distal end region of the outer catheter tube and a distal end secured to the distal end region of the inner catheter tube, whereby the distal end region of the inner catheter tube is enclosed within the expandable structure, the expandable structure being configured for introduction into bone while in a generally collapsed geometry and for assuming an expanded geometry inside bone.
Patent NZ-514934-A (NZ)
Title: Trabeculotomy device and method for treating glaucoma
Inventor: LYNCH MARY G
IPC: A61F9/00
Filed: 2000-04-26
Abstract: Surgical catheter devices and methods for decompressing elevated intraocular pressure in eyes affected by glaucoma by performing a selected trabeculotomy from within Schlemm's canal.
Patent NZ-516075-A (NZ)
Title: FAP-activated anti-tumour compounds
Inventor: PARK JOHN EDWARD
IPC: A61K47/48
Filed: 2000-05-11
Abstract: Disclosed are prodrugs capable of being converted into a drug by the catalytic action of human fibroblast activation protein (FAP alpha ), said prodrugs having a cleavage site which is recognised by FAP alpha , and said drug being cytotoxic or cytostatic under physiological conditions. Such drugs are compounds of formula (I) wherein: R1 represents a residue of formula Cg-A, Cg-B-A or Cg- (D)m- B-A, in which Cg represents a hydrogen atom, RS-CO, RS-O-CO- , RS-NH-CO-, RS-S02- or RS-, wherein R5 is an optionally substituted C1-C6-alkyl, C3-C8-cycloalkyl, aryl, aralkyl or heteroaryl group; A, is an amino acid; and D each independently represent moieties derived from amino carboxylic acids of the formula -[NR6-(X)p-CO]-wherein X represents CR7R8 and wherein R6, R7 and R8 each independently represent a hydrogen atom, an optionally substituted C1-C6-alkyl, C3-C8-cycloalkyl, aryl or heteroaryl group, and p is 1,2,3,4,5; or A, B and D each independently represent moieties derived from cyclic amino carboxylic acids Ra and Rb together with the interjacent N-C group form an optionally substituted, optionally benzo-or cyclohexano- condensed 3- to 7-membered saturated or unsaturated heterocyclic ring, in which one or two CH2 groups may also be replaced by NH, O or S, R4 represents H, C1-C6-alkyl, C3-C8-cycloalkyl, aryl or heteroaryl; and Cyt' represents the residue of a cytotoxic or cytostatic compound selected from the group consisting of anthracycline moieties of formula (II), wherein Rc represents C1-C6 alkyl, C1-C6 hydroxyalkyl C1-C6 alkanoyloxy C1-C6 alkyl; Rd represents hydrogen, hydroxy or C1-C6 alkoxy; one of Re and Rf represents hydrogen while the other is either hydrogen, a hydroxy or a tetrahydropyran-2-yloxy ( OTHP ) group.
Patent NZ-523300-A (NZ)
Title: Peristaltic pump head and tube holder
Inventor: GIBSON DAVID JOHN MICHAEL
IPC: F04B43/12
Filed: 2002-12-20
Abstract: A flexible container having a reservoir for holding fluid and comprising a tube holder directly connected to the flexible container, the tube holder having a tube race around a tapered aperture or recess configured for receipt of a tapered rotor of a peristaltic pump head, and a tube connector configured for connection to a resiliently flexible lube and in fluid communication with the reservoir, which tube holder can be brought into operable connection with the pump head to occlude fluid through a tube connected to the tube connector and extending around the tube race to dispense fluid from the container.
Patent NZ-524170-A (NZ)
Title: Preparations for diagnosis of pancreatic exocrine function
Inventor: ITO ASUKA
IPC: A61K49/00
Filed: 2001-08-31
Abstract: A preparation for the diagnosis of pancreatic exocrine function by determining the amount in which a substance administered to a subject or a degradation product or metabolite thereof migrates into the blood and/or is excreted out of the body, wherein the substance is carried by a carrier and released from the carrier when exposed to the action of a pancreatic exocrine function-related factor and wherein the carrier is composed of a material selected from the group consisting of materials containing an amide bond, materials containing a peptide bond, materials containing an alpha -1,4-glycoside bond, materials that can be dissolved at pH of the intestinal juice, and combinations thereof.
Patent NZ-526356-A (NZ)
Title: Indazolyl-substituted pyrroline compounds as kinase inhibitors
Inventor: ZHANG HAN-CHENG
IPC: A61P17/06
Filed: 2001-12-06
Abstract: A compound for Formula (I); a pharmaceutical composition comprising the compound; and the use of the compound in the preparation of a medicament for the treatment or amelioration of a kinase mediated disorder, such as diabetes; cardiovascular diseases e.g. acute stroke, heart failure, cardiovascular ischemia, thrombosis, atherosclerosis, hypertension, restenosis, retinopathy or prematurity and age-related macular degeneration; diabetes-associated disorders e.g. impaired glucose tolerance, diabetic retinopathy, proliferative retinopathy, retinal vein occlusion, macular edema, cardiomyopathy, nephropathy and neuropathy; inflammatory diseases e.g. vascular permeability, inflammation, asthma, rheumatoid arthritis and osteoarthritis; immunological disorders e.g. transplant tissue rejection, HIV-1 and PKC modulated immunological disorders, dermatological disorders e.g. psoriasis, hair loss and baldness; oncological disorders e.g. cancer or tumor growth, proliferative angiopathy and angiogenesis; and CNS disorders e.g. chronic pain, neuropathic pain, epilepsy, chronic neurodegenerative conditions, dementia, Alzheimer's disease, mood disorders, schizophrenia, manic depression and neurotraumatic, cognitive decline and ischemia-related diseases.
Patent NZ-528228-A (NZ)
Title: Method and device for manufacturing advanced water containing ultra-fine gold particles
Inventor: HIRATA YOSHIHIRO
IPC: B22F1/0545
Filed: 2002-02-26
Abstract: A method of manufacturing advanced water, comprising the steps of forming, at the top of a high-pressure water storage tank, a combustion chamber having an oxygen/hydrogen mixed gas injection nozzle, an ignition device, and a bar-like or a linear gold feeding device, igniting the oxygen/hydrogen mixed gas injection nozzle by the ignition device in the combustion chamber to melt the bar-like or linear gold fed from the linear metal feeding device or a gold foil and evaporate the gold-dissolved fluid so as to generate gold vapor, and bringing the gold vapor into contact with the high-pressure water to allow the generated ultra-fine gold particles to be dispersedly floated on water so as to finely disperse the ultra-fine gold particles and dissolve a small amount of gold in water, whereby the advanced water useful as healthy drinking water, health improving agency, cosmetics, food antiseptic, food freshness holding agent, noxious insect repellant, or deodorant can be manufactured.
Patent NZ-531068-A (NZ)
Title: Human papillomavirus E2 transactivation domain/inhibitor co-crystal and x-ray coordinates defining the inhibitor-binding pocket
Inventor: CAMERON DALE R
IPC: C12N15/09
Filed: 2002-07-12
Abstract: A crystallizable composition comprises an PV E2 TAD-like polypeptide of SEQ ID NO:2 complexed with an inhibitor L. Also described are methods for producing the crystallized PV E2 TAD inhibitor complex (PV E2 TAD-L) and x-ray crystal structure coordinates of the HPV E2 TAD-L complex which defines the inhibitor binding pocket. The inhibitor binding pocket is useful for screening potential small inhibitors that bind to the pocket.
Patent NZ-532188-A (NZ)
Title: Three-dimensional electroluminescence display which can withstand a high degree of curvature without damage
Inventor: ENZ EMIL
IPC: H05B33/00
Filed: 2002-10-24
Abstract: Disclosed is a three-dimensional electroluminescence display, comprising a main body and an electroluminescence device (20). The electroluminescence device comprises a film and an electroluminescent arrangement (10) which together form a whole. The surface of the film, facing the electroluminescent arrangement is provided with the motifs (9) for display. The electroluminescent arrangement comprises a front electrode (11) and a back electrode (12), between which a dielectric (13) is located. The front electrode is provided with the layer which produces the motif and is embodied in one piece with the same. A supply source is arranged within the surface of the electroluminescence device, which contacts the electrodes of the electroluminescence device.
Patent NZ-539162-A (NZ)
Title: Pyrazolopyrimidines as cyclin dependent kinase inhibitors
Inventor: GUZI TIMOTHY J
IPC: C07D487/04
Filed: 2003-09-03
Abstract: Disclosed are pyrazolopyrimidine compounds of formula (I), wherein; R is an optionally substituted heteroaryl, R2 is R9, alkyl, alkynyl, optionally substituted aryl, heteroaryl, CF3, heterocyclylalkyl, alkynylalkyl, cycloalkyl, -C(O)OR4, alkyl substituted with R9, and R3 is H, halogen, -NR5R6, -C(O)OR4, -C(O)NR5R6, optionally substituted alkyl, alkynyl, cycloalkyl, cycloalkylalkyl, aryl, arylalkyl, heterocyclyl, heterocyclylalkyl, heteroaryl. The compounds are used for the treatment of diseases mediated by cyclin dependent kinases.
Patent NZ-540267-A (NZ)
Title: Powder coating apparatus and process with fluidising bed and electrodes without ionisation or corona effects in bed
Inventor: KITTLE KEVIN JEFFREY
IPC: B05D1/24
Filed: 2003-12-11
Abstract: An apparatus for performing a process for forming a coating on a substrate (6), including a fluidising chamber (1) for establishing a fluidised-bed of a powder coating composition, means for immersing the substrate wholly or partly in the fluidised bed, the substrate (6) being either electrically isolated or earthed, an electrically conductive electrode (9), to which a voltage is applied, positioned to influence the extent to which charged particles adhere to a region of the substrate (6), means (8) for applying the voltage to the electrode (9), means for withdrawing the substrate from the fluidised-bed and means for forming the adherent particles into a continuous coating over at least part of the substrate, the apparatus being arranged to operate without ionisation or corona effects in the fluidised bed.
Patent NZ-546475-A (NZ)
Title: C-Class oligonucleotide analogs with enhanced immunostimulatory potency
Inventor: UHLMAN EUGEN
IPC: C07H21/02
Filed: 2004-10-29
Abstract: Disclosed are a number of immunostimulatory. The oligonucleotides of the invention can be used as adjuvants in vaccination. The oligonucleotides are also used for inducing an immune response, inducing expression of a type I interferon (IFN), inducing expression of gamma interferon (IFN-gamma), and for treating a variety of conditions, including allergy, asthma, infection, and cancer.
Patent NZ-547187-A (NZ)
Title: Wellbore gravel packing apparatus and method
Inventor: YEH CHARLES S
IPC: E21B43/04
Filed: 2004-10-14
Abstract: A well-bore apparatus and method for use in a well-bore for completion and production are disclosed. The apparatus comprises an outer permeable material (15) in the well-bore; a first base-pipe section (11) with at least a portion of the base-pipe having perforations (21), the first base-pipe is inside the outer permeable material and at least part of the perforated base-pipe is designed to be adjacent to a production interval (14) of the well-bore; a second base-pipe section (10) with at least a portion of the second base-pipe having slots (16), the second base-pipe is inside the outer permeable material and above the perforated base-pipe section, wherein at least a portion of the slotted base-pipe is designed to be adjacent to a non-production interval of the well-bore. The production completion apparatus may be installed into the well-bore to provide redundancy against well-screen failure.
Patent NZ-548314-A (NZ)
Title: Audio visual media storage and distribution in a local area network
Inventor: CLARK EVAN WILLIAM
IPC: G06F17/00
Filed: 2004-12-10
Abstract: Software for storing and distributing media in network is disclosed. The software comprises library program and a player program. The library program manages a plurality of encrypted media files, for example, video files and the player program displays the media files on an audio-visual devise such as a television. The player program is in network communication with the library program. The player program requests the media file from the library program and the library program sends the media file to the player program in an encrypted format. When the media file is completely received the player program decodes the file into an unencrypted format and displays the media file on the audiovisual device.
Patent NZ-548945-A (NZ)
Title: Liquid flow control device with swellable material partially surrounded by sealing material within body housing
Inventor: GUEST JOHN DEREK
IPC: F16K31/00
Filed: 2006-08-04
Abstract: The disclosure, with reference to Figs 1 and 2, relates to a liquid flow control device (10) having a port or passageway (11) through which liquid flow is to be controlled. A body (12) of a liquid swellable material is located in the port or passageway having an upstream side and a downstream side in relation to the direction of liquid flow through the port or passageway. A layer of sealing material (17) is provided on the upstream side of the body to prevent contact of that side of the body with the liquid when the body is swollen to close the port or passageway whilst allowing contact of the downstream side of the body when the body is in the non-swollen condition allowing liquid flow through the port or passageway. A similar embodiment is shown in Fig 3 using a ring of sealing material 35 within a an enclosure formed by a peripheral surrounding wall 29 of the body and end walls 26, 28.
Patent NZ-550822-A (NZ)
Title: Method for producing a composite product comprising a substrate material and a binder
Inventor: HODGSON THOMAS CLARENCE
Filed: 2001-11-23
Abstract: Disclosed is a method for producing a composite product including a substrate material and a binder, wherein either the binder includes a plastics material in an emulsion form, or a plastics material is added to an emulsion including the substrate material. Also disclosed are composite products, including a particulate substrate and particles of a plastics material therein.
Patent NZ-551209-A (NZ)
Title: Rheologically stabilized silicone dispersions
Inventor: SEROBIAN ASHKOT K
IPC: C11D3/00
Filed: 2005-05-05
Abstract: An aqueous dispersion comprising: (a) an organopolysiloxane fluid comprising at least two polydimethylsiloxanes with different viscosities; (b) a polymer selected from the group consisting of methylcellulose, hydroxypropyl methylcellulose, hydroxypropyl ethyl cellulose, dextrin, maltodextrin, polyvinyl alcohol, polyvinyl alcohol copolymers, xanthan gum, starch and mixtures thereof; (c) an additional polymer selected from the group consisting of polyacrylate polymers and copolymers which have a molecular weight of about 5,000 to about 5,000,000 g/mol; (d) at least 95 percent by weight water; and (e) a propellant. Also disclosed is the use of the dispersion for cleaning surfaces.
Patent NZ-552928-A (NZ)
Title: Antimicrobial silver compositions
Inventor: KARANDIKAR BHALCHANDRA M
IPC: C08J7/056
Filed: 2005-08-01
Abstract: Disclosed is a composition comprising, a solvent and elemental silver nanoparticles wherein the elemental silver nanoparticles are made by admixing in no particular order, an aqueous solution of a stabilizing agent, and an aqueous solution of a silver salt, and b) adding a tertiary diamine, wherein the tertiary diamine triggers the formation of elemental silver nanoparticles. The disclosure further relates to a method of treating a surface with elemental silver nanoparticles, comprising, (a) contacting a surface with a solution comprising silver nanoparticles for a time sufficient for an effective amount of nanoparticles to bind to the surface, and (b) rinsing the solution from the surface, wherein the elemental silver nanoparticles are made by admixing in no particular order, an aqueous solution of a stabilizing agent, and an aqueous solution of a silver salt, and (b) adding a tertiary diamine, wherein the tertiary diamine triggers the formation of elemental silver nanoparticles.
Patent NZ-561492-A (NZ)
Title: Interference control in a wireless communication system
Inventor: MESE MURAT
IPC: H04B7/005
Filed: 2006-03-15
Abstract: A method for interference control is disclosed. The method comprises: receiving at a base station an interference report from a neighbour base station, and regulation, by the base station data transmissions for terminals based on the interference report. The interference report indicates interference observed at the neighbour base station.
Patent NZ-561710-A (NZ)
Title: Alpha aminoacid ester-drug conjugates hydrolysable by carboxylesterase
Inventor: DAVIDSON ALAN HORNSBY
IPC: A61K47/48
Filed: 2006-05-04
Abstract: Disclosed is a covalent conjugate of an alpha amino acid ester and an inhibitor of the activity of a target intracellular enzyme, wherein: the ester group of the conjugate is hydrolysable by one or more intracellular carboxylesterase enzymes to the corresponding acid; and the alpha amino acid ester is conjugated to the inhibitor at a position remote from the binding interface between the inhibitor and the target enzyme, whereby the amino acid conjugate which is the hydrolysis product of the alpha amino acid ester conjugate retains the intracellular binding activity of the present inhibitor with the target enzyme. Also disclosed is a method of increasing or prolonging the intracellular potency and/or residence time of an inhibitor of the activity of a target intracellular enzyme.
Patent NZ-569670-A (NZ)
Title: Peptidomimetic protease inhibitors particular for the NS3 protease of Hepatitis C and act synergistically with anti-Hepatitis C compounds
Inventor: BABINE ROBERT EDWARD
IPC: C07K5/023
Filed: 2001-08-31
Abstract: Disclosed are the preparation and synthesis of peptidomimetic compounds of formula I, and use thereof in the manufacture of medicament of anti-viral pharmaceuticals. Particularly these peptidomimetic compounds are serine protease inhibitors and more particularly are hepatitis C virus NS3 protease inhibitors. Functional groups R1--R9 and Nitrogen-containing ring structures are described within. The pharmaceutical compound described herein comprises of a hepatitis C virus NS3 protease inhibitor of formula I and further comprising a compound having anti-hepatitis C virus activity.
Patent NZ-572068-A (NZ)
Title: Floor or wall covering removably fixed to an elastic intermediate layer by an adhesive
Inventor: VAN BERS FREDERIK JOHANNES
IPC: E04F15/18
Filed: 2007-03-07
Abstract: Disclosed is a floor consisting of floor elements (5, 6) placed on a base surface (1). An elastic layer is present between the floor elements (5, 6) and the base surface (1). The elastic layer has an adhesive layer (3) on at least one side, and the composition of the adhesive of the adhesive layer (3) is such that a self-adhesive effect is obtained after placement of the floor elements (5, 6), so that hardly any residual adhesive will remain behind on the floor elements (5, 6), if at all, after removal of the floor elements (5, 6) from the elastic layer (3). A method for laying such a floor is also disclosed.
Patent NZ-580868-A (NZ)
Title: Dosages and methods for the treatment of cancer
Inventor: LAUGHLIN MARK
IPC: C07D239/72
Filed: 2008-04-10
Abstract: Disclosed is a use of a compound in the manufacture of a medicament for treating cancer in a mammal for achieving in the mammal a plasma Cmax of about 10 ng/mL to about 30 ng/mL, comprising the compound (4-Methoxy-phenyl)-methyl-(2-methyl-quinazolin-4-yl)-amine hydrochloride, or a pharmaceutically acceptable salt or solvate thereof.
Patent NZ-583289-A (NZ)
Title: Binding molecules for treatment and detection of cancer
Inventor: GEUIJEN CECELIA ANNA WILHELMINA
IPC: A61K39/395
Filed: 2005-10-11
Abstract: Disclosed is an immunoglobulin molecule or antigen-binding fragment thereof capable of specifically binding to leukocyte antigen-related receptor protein tyrosine phosphatase. The disclosed immunoglobulin molecule comprises a specific heavy chain variable region and a specific light chain variable region, as defined in the specification. Also encompassed is the use of said immunoglobulin molecule in the manufacture of a medicament for treating cancer, in particular, acute myeloid leukaemia.
Patent NZ-585097-A (NZ)
Title: A device to mark bails of hay with paint using spray cans held in a cradle by a spring
Inventor: KELLY RICHARD KINGSWOOD
IPC: G01N22/04
Filed: 2008-08-06
Abstract: An apparatus for marking a bale (20) of bulk material is disclosed. The apparatus including a marking system to mark the bale and an operating means for controlling said marking system. The marking system includes a can of spray paint (26) housed in a cradle (28) and having a spray nozzle that can be actuated by a solenoid controlled by said operating means. The cradle has a spring loaded base to hold the can in place, the spring force of which exceeds the force that the solenoid is required to apply to actuate the spray nozzle. A microwave (22) detection system (14, 16) may control the marking system so that the marks indicate the moisture content of the bail. Multiple cans with different colours are envisaged.
Patent NZ-586250-A (NZ)
Title: Cell culture processes
Inventor: GIOVAGNOLI ANDRE
IPC: C07K14/00
Filed: 2008-12-22
Abstract: Disclosed is a method comprising culturing heterologous protein-secreting mammalian cells in a cell culture supernatant wherein the cell culture supernatant is maintained at a temperature that is set at X + 0.9oC, wherein X has a value of from 36.0 to 36.5, with the proviso that the temperature is set at less than 37oC, wherein the cell culture is maintained at a density of 1.4 x 106 to 2.8 x 106 cells/ml, and wherein the mammalian cell is a CHO cell.
Patent NZ-589008-A (NZ)
Title: A height adjustable abdominal exercise device where the supported knees of the user swing in arcs
Inventor: SPLANE ROBSON
IPC: A63B23/00
Filed: 2009-08-27
Abstract: An exercise device (100) is disclosed. The device has a base (102), first (106) and second (108) knee supports which are bilaterally coupled to first and second pivots located off from the centre of the base. Independently rotatable knee pads (110, 112) are coupled to the perimeter-side end of the first and second knee supports arranged around a perimeter (116) of the base. An upper extremity support (114) is coupled to the base, and a first base supporting member is positioned at a rear of the base. A second base supporting member is positioned at a front of the base, wherein at least one of an inclination and elevation of the base is determined by adjustment of at least one of the base supporting members. The first and second knee supports move around different arcs to generate an elliptical motion for an individual.
Patent NZ-590881-A (NZ)
Title: A heat sealing machine to seal a film to a tray on each of two substantially normal faces
Inventor: NIVEN NORMAN
IPC: B29C65/02
Filed: 2009-06-26
Abstract: A heat sealing machine for applying heat at predetermined positions on a heat sealable film (21) placed over a compartmented tray (10) to seal the film to the tray on two substantially normal planes. The machine has a heated plate (30) adapted to bear upon the heat sealable film (21) on a first plane over the compartmented tray (10) and a spring loaded pressure plate (32) adapted to bear upon the heated plate (30). A supplementary heated member (36) is movable with respect to the heated plate (30) and has a pressure member (37) adapted to bear against the heat sealable film (21) over a surface of the compartmented tray (15) on a second plane.